SCHEDULE 13G

Company

Moleculin Biotech, Inc.

Filed

February 23, 2018

Accession Number

0001213900-18-002249

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →